(MENAFN- EIN Presswire)
U.S. Sterile Injectables Market
U.S sterile injectables market is estimated to be valued at US$ 131.8 billion in 2022 and expected to exhibit a CAGR of 9.3% over the forecast period 2022-2030
BURLINGAME, CA, UNITED STATES, September 11, 2024 /EINPresswire / -- The latest market intelligence report published by CMI with the title "U.S. Sterile Injectables Market 2024, Growth Opportunities, and Forecast" provides actionable insights on
Pharmaceutical industry. The report provides demand analysis,
industry insights, competitive intelligence, and customer database.
The Research report on U.S. Sterile Injectables Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also provides and a lot of business matrices including Porters Five Forces Analysis, PESTLE Analysis, Value Chain Analysis, 4 Ps' Analysis, Market Attractiveness Analysis, BPS Analysis, Ecosystem Analysis.
Do you think, if this report could be of your interest? If yes, request Sample Copy of this Report: : -
*Note: Sample of the report provides details on the scope and coverage, table of contents, research methodology, and Sample Framework of the report. Actual report of 150+ is available for purchase to all the interested stakeholders.
*Key trends*
Rising Popularity of Biosimilars: Lower costs and proven efficacy are accelerating biosimilar adoption. By 2031, biosimilars could capture over 30% market share in the US.
Increased Focus on Specialty Therapeutics: Companies are investing heavily in complex drug formulations like liposomes and polymeric conjugates to treat rare diseases. Global specialty injectables sales may surpass $200 billion by 2031.
Strong Pipeline of Novel Drugs: Over 500 new injectable drug candidates are in clinical trials focused on oncology, neurology and autoimmune diseases. Successful approvals could open major new revenue streams.
Shift Towards Value-Based Care: Payers and providers are prioritizing cost-effective outcomes-based contracts to curb healthcare spending. Sterile injectables with clear patient benefits will see preferential reimbursement.
Surge in Ambulatory Infusion Centers: Outpatient facilities are eliminating the need for IV therapy in hospitals, improving accessibility and comfort for patients. Their expanding networks could lower treatment costs by 30-50%.
Want to access more insights? The journey starts from requesting Sample: : -
*Note: Sample of the report provides details on the scope and coverage, table of contents, research methodology, and Sample Framework of the report. Actual report of 150+ is available for purchase to all the interested stakeholders.
Detailed Segmentation and Classification of the report (Market Size and Forecast – 2031, Y-o-Y growth rate, and CAGR):
By Molecule Type: Large Molecule, Small Molecule
By Drug Type: Monoclonal Antibody (mAbs), Cytokines, Insulin, Peptide Hormones, Vaccines, Immunoglobulins, Blood Factors, Peptide Antibiotics, Others
By Therapeutic Application: Cancer, Metabolic Diseases, Cardiovascular Diseases, Central Nervous System Disorder, Infectious Diseases, Musculoskeletal Disorders, Others
By Route of Administration: Subcutaneous (SC), Intravenous (IV), Intramuscular (IM), Others
By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Following are the players analyzed in the report:
Baxter International Inc.
AstraZeneca plc
Merck & Co. Inc.
Novartis AG
Johnson & Johnson Services Inc.
Gilead Sciences Inc.
JHP Pharmaceuticals
Pfizer Inc.
Fresenius Kabi Ag
CordenPharma
Hikma Pharmaceuticals PLC.
Get access to the latest Edition of this Market Study (comprising 150+ pages) and Get Up to 25% Discount: :
Deep-dive Analysis:
The Report provides deep-dive qualitative and quantitative analysis on U.S. Sterile Injectables Market for all the regions and countries covered below:
➢ North America (the United States, Canada, and Mexico)
➢ Europe (Germany, France, Italy, United Kingdom, SCANDIVAN, Benelux, Russia, and Rest of Europe)
➢ Asia-Pacific (Japan, South Korea, India, China, Southeast Asia, and Australia)
➢ South America (Brazil, Argentina, and Rest of South America)
➢ Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa, and Rest of the Middle East & Africa)
➢ Each Country is covered in detail, and report provides qualitative and quantitative analysis on U.S. Sterile Injectables Market on each country.
The research provides answers to the following key questions:
1.What is the estimated growth rate of the market for the forecast period 2024-2031? What will be the market size during the estimated period?
2.What are the key driving forces responsible for shaping the fate of the U.S. Sterile Injectables market during the forecast period?
3.Who are the major market vendors and what are the winning strategies that have helped them occupy a strong foothold in the U.S. Sterile Injectables market?
4.What are the prominent market trends influencing the development of the U.S. Sterile Injectables market across different regions?
5.What are the major threats and challenges likely to act as a barrier in the growth of the U.S. Sterile Injectables market?
6.What are the major opportunities the market leaders can rely on to gain success and profitability?
Key insights provided by the report that could help you take critical strategic decisions?
. Regional report analysis highlighting the consumption of products/services in a region also shows the factors that influence the market in each region.
. Reports provide opportunities and threats faced by suppliers in the U.S. Sterile Injectables and tubes industry around the world.
. The report shows regions and sectors with the fastest growth potential.
. A competitive environment that includes market rankings of major companies, along with new product launches, partnerships, business expansions, and acquisitions.
. The report provides an extensive corporate profile consisting of company overviews, company insights, product benchmarks, and SWOT analysis for key market participants.
. This report provides the industry's current and future market outlook on the recent development, growth opportunities, drivers, challenges, and two regional constraints emerging in advanced regions.
. This report provides the industry's current and future market outlook on the recent development, growth opportunities, drivers, challenges, and two regional constraints emerging in advanced regions.
Author of this marketing PR:
Alice Mutum is a seasoned senior content editor at Coherent Market Insights, leveraging extensive expertise gained from her previous role as a content writer. With seven years in content development, Alice masterfully employs SEO best practices and cutting-edge digital marketing strategies to craft high-ranking, impactful content. As an editor, she meticulously ensures flawless grammar and punctuation, precise data accuracy, and perfect alignment with audience needs in every research report. Alice's dedication to excellence and her strategic approach to content make her an invaluable asset in the world of market insights.
About Us:
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Mr. Shah
Coherent Market Insights Pvt. Ltd.
+1 206-701-6702
email us here
Visit us on social media:
Facebook
X
LinkedIn
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
MENAFN11092024003118003196ID1108661643